Anakinra efficacy in a Caucasian patient with renal AA amyloidosis secondary to cryopyrin-associated periodic syndrome

Joint Bone Spine

Volumn 77, Issue 6, 2010, Pages 616-617

  Aït Abdesselam, Tassadit ^a   Lequerré, Thierry ^a   Legallicier, Bruno ^a   François, Arnaud ^a   Le Loët, Xavier ^a   Vittecoq, Olivier ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

Anakinra; Cryopyrin associated periodic syndrome; Renal AA amyloidosis

Indexed keywords

METHOTREXATE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE;

ADULT; CASE REPORT; CAUCASIAN; CINCA SYNDROME; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HYPOALBUMINEMIA; KIDNEY AMYLOIDOSIS; KIDNEY BIOPSY; LABORATORY TEST; LETTER; MUCKLE WELLS SYNDROME; PATIENT COMPLIANCE; PERIPHERAL EDEMA; POLYARTHRITIS; PROTEINURIA; REMISSION; RENAL AA AMYLOIDOSIS;

ADULT; AMYLOIDOSIS; ANTIRHEUMATIC AGENTS; CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; KIDNEY GLOMERULUS; NEPHROTIC SYNDROME; REMISSION INDUCTION; SERUM AMYLOID A PROTEIN; TREATMENT OUTCOME;

EID: 78649907431     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2010.04.018     Document Type: Letter

References (10)

1. Stojanov S., Kastner D.L. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 2005, 17:586-599.
2. Lequerré T., Vittecoq O., Saugier-Veber P., et al. A cryopyrin-associated periodic syndrome with joint destruction. Rheumatology (Oxford) 2007, 46:709-714.
3. Yamazaki T., Masumoto J., Agematsu K., et al. Anakinra improves sensory deafness in a Japanese patient with Muckle-Wells syndrome, possibly by inhibiting the cryopyrin inflammasome. Arthritis Rheum 2008, 58:864-868.
4. Maksimovic L., Stirnemann J., Caux F., et al. New CIAS1 mutation and anakinra efficacy in overlapping of Muckle-Wells and familial cold autoinflammatory syndromes. Rheumatology (Oxford) 2008, 47:309-310.
5. Dybowski F., Jakobs B., Altmeyer P., et al. Successful treatment of clinical manifestations of Muckle-Wells syndrome with anakinra. Dtsch Med Wochenschr 2006, 25:1863-1866.
6. Hawkins P.N., Lachmann H.J., Aganna E., et al. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 2004, 50:607-612.
7. Goldbach-Mansky R., Dailey N.J., Canna S.W., et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med 2006, 355:581-592.
8. Hoffman H.M., Rosengren S., Boyle D.L., et al. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 2004, 364:1779-1785.
9. Thornton B.D., Hoffman H.M., Bhat A., et al. Successful treatment of renal amyloidosis due to familial cold autoinflammatory syndrome using an interleukin 1 receptor antagonist. Am J Kidney Dis 2007, 49:477-481.
10. Leslie K.S., Lachmann H.J., Bruning E., et al. Phenotype, genotype, and sustained response to anakinra in 22 patients with auto inflammatory disease associated with CIAS-1/NALP3 mutations. Arch Dermatol 2006, 142:1591-1597.